vs
Akebia Therapeutics, Inc.（AKBA）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是Akebia Therapeutics, Inc.的1.6倍（$94.3M vs $57.6M），Akebia Therapeutics, Inc.同比增速更快（23.9% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $31.1M），过去两年Akebia Therapeutics, Inc.的营收复合增速更高（32.9% vs -11.5%）
Akebia Therapeutics是一家专注于肾病领域的生物制药企业，核心业务覆盖药物研发、临床试验及商业化推广全流程，主要开发针对慢性肾病相关贫血等适应症的创新疗法，面向全球市场，致力于满足肾病治疗领域未被满足的临床需求。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
AKBA vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.6倍
$57.6M
营收增速更快
AKBA
高出18.6%
5.3%
自由现金流更多
RBCAA
多$130.0M
$31.1M
两年增速更快
AKBA
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $94.3M |
| 净利润 | — | $22.8M |
| 毛利率 | 78.2% | — |
| 营业利润率 | -14.8% | 29.3% |
| 净利率 | — | 24.2% |
| 营收同比 | 23.9% | 5.3% |
| 净利润同比 | — | 20.0% |
| 每股收益（稀释后） | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AKBARBCAA
| Q4 25 | $57.6M | $94.3M | ||
| Q3 25 | $58.8M | $93.5M | ||
| Q2 25 | $62.5M | $93.8M | ||
| Q1 25 | $57.3M | $135.8M | ||
| Q4 24 | $46.5M | $89.5M | ||
| Q3 24 | $37.4M | $88.1M | ||
| Q2 24 | $43.6M | $86.9M | ||
| Q1 24 | $32.6M | $120.3M |
净利润AKBARBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $540.0K | $29.7M | ||
| Q2 25 | $247.0K | $31.5M | ||
| Q1 25 | $6.1M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-20.0M | $26.5M | ||
| Q2 24 | $-8.6M | $25.2M | ||
| Q1 24 | $-18.0M | $30.6M |
毛利率AKBARBCAA
| Q4 25 | 78.2% | — | ||
| Q3 25 | 84.0% | — | ||
| Q2 25 | 84.1% | — | ||
| Q1 25 | 86.7% | — | ||
| Q4 24 | 56.2% | — | ||
| Q3 24 | 62.2% | — | ||
| Q2 24 | 60.9% | — | ||
| Q1 24 | 64.4% | — |
营业利润率AKBARBCAA
| Q4 25 | -14.8% | 29.3% | ||
| Q3 25 | 7.6% | 40.4% | ||
| Q2 25 | 22.6% | 43.0% | ||
| Q1 25 | 23.6% | 44.1% | ||
| Q4 24 | -30.8% | 25.8% | ||
| Q3 24 | -33.4% | 38.4% | ||
| Q2 24 | -20.0% | 37.0% | ||
| Q1 24 | -45.8% | 32.2% |
净利率AKBARBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | 0.9% | 31.8% | ||
| Q2 25 | 0.4% | 33.5% | ||
| Q1 25 | 10.7% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -53.5% | 30.1% | ||
| Q2 24 | -19.7% | 29.0% | ||
| Q1 24 | -55.2% | 25.4% |
每股收益（稀释后）AKBARBCAA
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $-0.10 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.8M | $220.0M |
| 总债务越低越好 | $48.3M | — |
| 股东权益账面价值 | $32.6M | $1.1B |
| 总资产 | $376.6M | $7.0B |
| 负债/权益比越低杠杆越低 | 1.48× | — |
8季度趋势，按日历期对齐
现金及短期投资AKBARBCAA
| Q4 25 | $184.8M | $220.0M | ||
| Q3 25 | $166.4M | $484.2M | ||
| Q2 25 | $137.3M | $484.8M | ||
| Q1 25 | $113.4M | $793.0M | ||
| Q4 24 | $51.9M | $432.2M | ||
| Q3 24 | $34.0M | $530.9M | ||
| Q2 24 | $39.5M | $400.1M | ||
| Q1 24 | $42.0M | $546.4M |
总债务AKBARBCAA
| Q4 25 | $48.3M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $47.1M | — | ||
| Q1 25 | $46.5M | — | ||
| Q4 24 | $38.7M | — | ||
| Q3 24 | $38.4M | — | ||
| Q2 24 | $38.0M | — | ||
| Q1 24 | $30.1M | — |
股东权益AKBARBCAA
| Q4 25 | $32.6M | $1.1B | ||
| Q3 25 | $41.6M | $1.1B | ||
| Q2 25 | $29.2M | $1.1B | ||
| Q1 25 | $24.6M | $1.0B | ||
| Q4 24 | $-49.2M | $992.0M | ||
| Q3 24 | $-50.4M | $979.7M | ||
| Q2 24 | $-33.8M | $955.4M | ||
| Q1 24 | $-27.3M | $935.6M |
总资产AKBARBCAA
| Q4 25 | $376.6M | $7.0B | ||
| Q3 25 | $364.2M | $7.0B | ||
| Q2 25 | $345.6M | $7.0B | ||
| Q1 25 | $310.2M | $7.1B | ||
| Q4 24 | $220.7M | $6.8B | ||
| Q3 24 | $207.1M | $6.7B | ||
| Q2 24 | $220.2M | $6.6B | ||
| Q1 24 | $225.5M | $6.9B |
负债/权益比AKBARBCAA
| Q4 25 | 1.48× | — | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.61× | — | ||
| Q1 25 | 1.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.1M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $161.1M |
| 自由现金流率自由现金流/营收 | 53.9% | 170.9% |
| 资本支出强度资本支出/营收 | 0.1% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $67.7M | $288.6M |
8季度趋势，按日历期对齐
经营现金流AKBARBCAA
| Q4 25 | $31.1M | $168.2M | ||
| Q3 25 | $28.1M | $33.3M | ||
| Q2 25 | $22.3M | $8.4M | ||
| Q1 25 | $-13.6M | $93.2M | ||
| Q4 24 | $-4.5M | $149.0M | ||
| Q3 24 | $-6.7M | $51.3M | ||
| Q2 24 | $-10.1M | $4.0M | ||
| Q1 24 | $-19.4M | $71.2M |
自由现金流AKBARBCAA
| Q4 25 | $31.1M | $161.1M | ||
| Q3 25 | $28.0M | $30.8M | ||
| Q2 25 | $22.2M | $5.2M | ||
| Q1 25 | $-13.6M | $91.6M | ||
| Q4 24 | $-4.5M | $143.2M | ||
| Q3 24 | $-6.7M | $49.8M | ||
| Q2 24 | $-10.1M | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率AKBARBCAA
| Q4 25 | 53.9% | 170.9% | ||
| Q3 25 | 47.7% | 32.9% | ||
| Q2 25 | 35.6% | 5.5% | ||
| Q1 25 | -23.7% | 67.4% | ||
| Q4 24 | -9.6% | 160.0% | ||
| Q3 24 | -17.9% | 56.5% | ||
| Q2 24 | -23.1% | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度AKBARBCAA
| Q4 25 | 0.1% | 7.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率AKBARBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | 52.05× | 1.12× | ||
| Q2 25 | 90.47× | 0.27× | ||
| Q1 25 | -2.22× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AKBA
| Auryxia | $48.1M | 84% |
| Vafseo | $6.2M | 11% |
| License Collaboration And Other Revenue | $3.3M | 6% |
RBCAA
暂无分部数据
